Literature DB >> 20109452

Inhibitory effect of ursolic acid derivatives on hydrogen peroxide- and glutathione-mediated degradation of hemin: a possible additional mechanism of action for antimalarial activity.

Catherine Mullié1, Alexia Jonet, Alexandra Dassonville-Klimpt, Grace Gosmann, Pascal Sonnet.   

Abstract

Compounds obtained by the condensation of ursolic acid (UA) with 1,4-bis(3-aminopropyl)piperazines have previously been shown as cytocidal to Plasmodium falciparum strains. Preliminary results indicated that the inhibition of beta-hematin formation (one of the possible mechanisms of action of antimalarial drugs) was achieved by a few of these molecules with varying efficiencies. To gain further insight in the antimalarial action of UA derivatives, we report here the results of additional pathways that may explain their in vitro cytocidal activity such as inhibition of hemin degradation by H(2)O(2) or glutathione (GSH). H(2)O(2)-mediated hemin degradation was drastically reduced by hydroxybenzyl-substituted UA derivatives while UA and intermediate compounds displayed weaker inhibitory actions. The results of GSH-mediated hemin degradation inhibition did not parallel those of H(2)O(2) degradation as hydroxybenzyl-substituted UA only proved to be a weak inhibitor. As H(2)O(2) interaction with the iron moiety of hemin is the first step towards its degradation, we assume that the interaction of our products with the ferric ion in the hemin structure is of upmost importance in inhibiting its peroxidative degradation. A two-step mechanism of action implying (1) stacking of the acetylursolic acid structure to hemin and (2) additive protection of hemin ferric iron from H(2)O(2) by hydroxyphenyl groups through steric hindrance and/or trapping of oxygen reactive species in the direct neighborhood of ferric iron can be put forward. For GSH degradation pathway, grafting of UA structure with a piperazine structure gave the best inhibition, pleading for the implication of this latter moiety in the inhibitory process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109452     DOI: 10.1016/j.exppara.2010.01.016

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

1.  Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages.

Authors:  Carlos Moneriz; Patricia Marín-García; Andrés García-Granados; José M Bautista; Amalia Diez; Antonio Puyet
Journal:  Malar J       Date:  2011-04-10       Impact factor: 2.979

2.  Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action.

Authors:  Catherine Mullié; Alexia Jonet; Camille Desgrouas; Nicolas Taudon; Pascal Sonnet
Journal:  Malar J       Date:  2012-03-08       Impact factor: 2.979

3.  Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.

Authors:  Jichuang Wang; Zhou Jiang; Liping Xiang; Yuanfang Li; Minrui Ou; Xiang Yang; Jingwei Shao; Yusheng Lu; Lifeng Lin; Jianzhong Chen; Yun Dai; Lee Jia
Journal:  Sci Rep       Date:  2014-05-21       Impact factor: 4.379

4.  A pentacyclic triterpene natural product, ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis.

Authors:  Liping Xiang; Ting Chi; Qiao Tang; Xiang Yang; Minrui Ou; Xiufen Chen; Xiaobo Yu; Jianzhong Chen; Rodney J Y Ho; Jingwei Shao; Lee Jia
Journal:  Oncotarget       Date:  2015-04-20

5.  A Validated HPLC-PDA-HRMS Method to Investigate the Biological Stability and Metabolism of Antiparasitic Triterpenic Esters.

Authors:  Laura Schioppa; Fanta Fall; Sergio Ortiz; Jacques H Poupaert; Joelle Quetin-Leclercq
Journal:  Molecules       Date:  2021-11-26       Impact factor: 4.411

6.  Two series of new semisynthetic triterpene derivatives: differences in anti-malarial activity, cytotoxicity and mechanism of action.

Authors:  Gloria N S da Silva; Nicole R G Maria; Desirée C Schuck; Laura N Cruz; Miriam S de Moraes; Myna Nakabashi; Cedric Graebin; Grace Gosmann; Célia R S Garcia; Simone C B Gnoatto
Journal:  Malar J       Date:  2013-03-09       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.